Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oxford Immunotec Global PLC (NASDAQ:OXFD)

13.71
Delayed Data
As of Nov 20
 +0.21 / +1.56%
Today’s Change
12.19
Today|||52-Week Range
19.51
-8.29%
Year-to-Date
No recent news for Oxford Immunotec Global PLC.

Today’s Trading

Previous close13.50
Today’s open13.51
Day’s range13.51 - 13.75
Volume176,111
Average volume (3 months)124,230
Market cap$346.3M
Dividend yield--
Data as of 4:00pm ET, 11/20/2017

Growth & Valuation

Earnings growth (last year)+10.71%
Earnings growth (this year)-112.25%
Earnings growth (next 5 years)--
Revenue growth (last year)+37.11%
P/E ratioNM
Price/Sales3.88
Price/Book4.19

Competitors

 Today’s
change
Today’s
% change
CLDXCelldex Therapeutics...-0.05-1.72%
VCYTVeracyte Inc+0.22+3.56%
VIVOMeridian Bioscience ...-0.10-0.67%
CALACalithera Bioscience...-0.15-1.46%
Data as of 4:00pm ET, 11/20/2017

Financials

Next reporting dateMarch 6, 2018
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$86.1M
Annual profit (last year)-$22.3M
Net profit margin-25.96%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Executive Director
Peter James Wrighton-Smith
Chief Operating Officer
Stefan C. Linn
Corporate headquarters
Abingdon, Oxfordshire

Forecasts